---
title: First Quarter Financial Report 2019
description: "First quarter financial report 2019: Gentian Diagnostics AS announces its results for the first quarter of 2019. Read more:"
---

Moss, 9.5.2019

 

Gentian Diagnostics AS announces its results for the first quarter of 2019. The highlights include:

- Good start to the new fiscal year with sales revenues of MNOK 10.6 for the quarter.
- Record sales achieved for fCAL®turbo, our innovative biomarker for the diagnosis of inflammatory bowel disease.
- New scientific study results confirm GCAL as a promising biomarker for the diagnosis of bacterial infections.

 

Please find the report and results presentation enclosed. The documents is also available on [Oslo Børs](https://newsweb.oslobors.no/message/476431).

 

**[Q1 2019 GD Interim presentation](https://www.gentian.com/hubfs/Q1-2019-GD-Interim-presentation.pdf)**

**[Q1 2019 GD Interim report](https://www.gentian.com/hubfs/Q1-2019-GD-Interim-report.pdf)**

**For further information, please contact:**

Hilja Ibert  
CEO, Gentian Diagnostics  
E-mail: [hilja.ibert@gentian.no](mailto:hilja.ibert@gentian.no)  
Cell Phone: +47 919 05 242

Njaal Kind  
CFO, Gentian Diagnostics  
E-mail: [njaal.kind@gentian.no](mailto:njaal.kind@gentian.no)  
Cell Phone: +47 919 06 525

**MeldingsID: **476431  
**UtstederID: **GENT-ME  
**Instrument: **GENT-ME  
**Marked: **Merkur Market  
**Kategori: **HALVÅRSRAPPORTER OG REVISJONSBERETNINGER / UTTALELSER OM FORENKLET REVISORKONTROLL

 

### You may also read

[Jul 02, 2026 - Ole Sørlie](https://www.gentian.com/investor-relations-stock-information/investors-news/first-quarter-financial-report-year-2019#)

##### [Gentian Diagnostics: Invitation to presentation of second quarter results](https://www.gentian.com/investor-relations-stock-information/investors-news/gentian-diagnostics-invitation-to-presentation-of-second-quarter-results-1)

Gentian Diagnostics ASA will present its second quarter 2026 results on 9 July 2026 at 09.00 CEST. The..

[Read more](https://www.gentian.com/investor-relations-stock-information/investors-news/gentian-diagnostics-invitation-to-presentation-of-second-quarter-results-1)

[Jun 24, 2026 - Ole Sørlie](https://www.gentian.com/investor-relations-stock-information/investors-news/first-quarter-financial-report-year-2019#)

##### [ESSANGE REAGENTS AND GENTIAN DIAGNOSTICS ANNOUNCE COLLABORATION AGREEMENT](https://www.gentian.com/investor-relations-stock-information/investors-news/essange-reagents-and-gentian-diagnostics-announce-collaboration-agreement)

Amsterdam / Moss, 24 June 2026 ESSANGE REAGENTS AND GENTIAN DIAGNOSTICS ANNOUNCE COLLABORATION AGREEMENT..

[Read more](https://www.gentian.com/investor-relations-stock-information/investors-news/essange-reagents-and-gentian-diagnostics-announce-collaboration-agreement)

[May 29, 2026 - Ole Sørlie](https://www.gentian.com/investor-relations-stock-information/investors-news/first-quarter-financial-report-year-2019#)

##### [Mandatory notification of trade](https://www.gentian.com/investor-relations-stock-information/investors-news/mandatory-notification-of-trade-1780055230560)

Moss, 29 May 2026 Gentian Diagnostics ASA ("Gentian") has today been notified that the following transaction..

[Read more](https://www.gentian.com/investor-relations-stock-information/investors-news/mandatory-notification-of-trade-1780055230560)